Skip to Content Skip to Search

Company

A new era for human health

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

A signal for change
Close Video

Scroll to explore

Our strategy

We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.

Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

Infectious diseases
1 in 3
of us will be affected by shingles in our lifetime
HIV
38m
people are living with HIV worldwide
Oncology
~10m
people died from cancer in 2020, making it a leading cause of death worldwide
Immunology
25yrs
of leading research to help people with inflammatory conditions
Life at GSK

How we help people thrive 

Studio portrait - light background - 8

Culture

Man smiling

Growth

Man smiling

Diversity, equity and inclusion

Scientists conversing over skeletal formulae

Wellbeing

icon

INVESTORS

We announced our second quarter 2022 results on Wednesday 27 July.

View latest results
Back to top